Versatile and Robust Method for Antibody Conjugation to Nanoparticles with High Targeting Efficiency
-
- Indra Van Zundert
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
-
- Maria Bravo
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
-
- Olivier Deschaume
- Soft-Matter Physics and Biophysics, Department of Physics and Astronomy, KU Leuven, Celestijnenlaan 200D, Box 2416, 3001 Heverlee, Belgium
-
- Pierre Cybulski
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
-
- Carmen Bartic
- Soft-Matter Physics and Biophysics, Department of Physics and Astronomy, KU Leuven, Celestijnenlaan 200D, Box 2416, 3001 Heverlee, Belgium
-
- Johan Hofkens
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
-
- Hiroshi Uji-i
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
-
- Beatrice Fortuni
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
-
- Susana Rocha
- Molecular Imaging and Photonics, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, 3001 Heverlee, Belgium
書誌事項
- 公開日
- 2021-12-14
- 権利情報
-
- https://creativecommons.org/licenses/by/4.0/
- DOI
-
- 10.3390/pharmaceutics13122153
- 10.1101/2021.09.29.462399
- 公開者
- MDPI AG
説明
<jats:p>The application of antibodies in nanomedicine is now standard practice in research since it represents an innovative approach to deliver chemotherapy agents selectively to tumors. The variety of targets or markers that are overexpressed in different types of cancers results in a high demand for antibody conjugated-nanoparticles, which are versatile and easily customizable. Considering up-scaling, the synthesis of antibody-conjugated nanoparticles should be simple and highly reproducible. Here, we developed a facile coating strategy to produce antibody-conjugated nanoparticles using ‘click chemistry’ and further evaluated their selectivity towards cancer cells expressing different markers. Our approach was consistently repeated for the conjugation of antibodies against CD44 and EGFR, which are prominent cancer cell markers. The functionalized particles presented excellent cell specificity towards CD44 and EGFR overexpressing cells, respectively. Our results indicated that the developed coating method is reproducible, versatile, and non-toxic, and can be used for particle functionalization with different antibodies. This grafting strategy can be applied to a wide range of nanoparticles and will contribute to the development of future targeted drug delivery systems.</jats:p>
収録刊行物
-
- Pharmaceutics
-
Pharmaceutics 13 (12), 2153-, 2021-12-14
MDPI AG
- Tweet
キーワード
- EGFR
- 3214 Pharmacology and pharmaceutical sciences
- CELLULAR UPTAKE
- PROSPECTIVE IDENTIFICATION
- Article
- Pharmacy and materia medica
- MESOPOROUS SILICA NANOPARTICLES
- Pharmacology & Pharmacy
- DRUG-DELIVERY
- CANCER-CELLS
- CD44
- mesoporous silica nanoparticles
- Science & Technology
- ENHANCED PERMEABILITY
- IN-VITRO
- RS1-441
- antibody functionalization
- GOLD NANOPARTICLES
- targeted drug delivery systems
- 1115 Pharmacology and Pharmaceutical Sciences
- Life Sciences & Biomedicine
- mesoporous silica nanoparticles; antibody functionalization; targeted drug delivery systems